137 related articles for article (PubMed ID: 10212185)
1. Nucleotide occlusion in the human cystic fibrosis transmembrane conductance regulator. Different patterns in the two nucleotide binding domains.
Szabó K; Szakács G; Hegeds T; Sarkadi B
J Biol Chem; 1999 Apr; 274(18):12209-12. PubMed ID: 10212185
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator.
Ketchum CJ; Rajendrakumar GV; Maloney PC
Biochemistry; 2004 Feb; 43(4):1045-53. PubMed ID: 14744150
[TBL] [Abstract][Full Text] [Related]
3. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
Basso C; Vergani P; Nairn AC; Gadsby DC
J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
[TBL] [Abstract][Full Text] [Related]
4. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
[TBL] [Abstract][Full Text] [Related]
6. Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator.
Aleksandrov L; Mengos A; Chang X; Aleksandrov A; Riordan JR
J Biol Chem; 2001 Apr; 276(16):12918-23. PubMed ID: 11279083
[TBL] [Abstract][Full Text] [Related]
7. Differences between cystic fibrosis transmembrane conductance regulator and HisP in the interaction with the adenine ring of ATP.
Berger AL; Welsh MJ
J Biol Chem; 2000 Sep; 275(38):29407-12. PubMed ID: 10893239
[TBL] [Abstract][Full Text] [Related]
8. Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia.
Dong Q; Ernst SE; Ostedgaard LS; Shah VS; Ver Heul AR; Welsh MJ; Randak CO
J Biol Chem; 2015 May; 290(22):14140-53. PubMed ID: 25887396
[TBL] [Abstract][Full Text] [Related]
9. Covalent modification of the nucleotide binding domains of cystic fibrosis transmembrane conductance regulator.
Cotten JF; Welsh MJ
J Biol Chem; 1998 Nov; 273(48):31873-9. PubMed ID: 9822656
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis transmembrane conductance regulator: a chloride channel gated by ATP binding and hydrolysis.
Bompadre SG; Hwang TC
Sheng Li Xue Bao; 2007 Aug; 59(4):431-42. PubMed ID: 17700963
[TBL] [Abstract][Full Text] [Related]
12. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
Yu YC; Sohma Y; Hwang TC
J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog.
Bompadre SG; Li M; Hwang TC
J Biol Chem; 2008 Feb; 283(9):5364-9. PubMed ID: 18167357
[TBL] [Abstract][Full Text] [Related]
14. Mg2+ -dependent ATP occlusion at the first nucleotide-binding domain (NBD1) of CFTR does not require the second (NBD2).
Aleksandrov L; Aleksandrov A; Riordan JR
Biochem J; 2008 Nov; 416(1):129-36. PubMed ID: 18605986
[TBL] [Abstract][Full Text] [Related]
15. How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
Zwick M; Esposito C; Hellstern M; Seelig A
J Biol Chem; 2016 Jul; 291(28):14483-98. PubMed ID: 27226582
[TBL] [Abstract][Full Text] [Related]
16. Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulator.
Cantiello HF; Jackson GR; Grosman CF; Prat AG; Borkan SC; Wang Y; Reisin IL; O'Riordan CR; Ausiello DA
Am J Physiol; 1998 Mar; 274(3):C799-809. PubMed ID: 9530112
[TBL] [Abstract][Full Text] [Related]
17. The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.
Aleksandrov L; Aleksandrov AA; Chang XB; Riordan JR
J Biol Chem; 2002 May; 277(18):15419-25. PubMed ID: 11861646
[TBL] [Abstract][Full Text] [Related]
18. Function of the R domain in the cystic fibrosis transmembrane conductance regulator chloride channel.
Ma J; Zhao J; Drumm ML; Xie J; Davis PB
J Biol Chem; 1997 Oct; 272(44):28133-41. PubMed ID: 9346969
[TBL] [Abstract][Full Text] [Related]
19. Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl
Chen JH; Xu W; Sheppard DN
J Physiol; 2017 Feb; 595(4):1059-1076. PubMed ID: 27779763
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of recombinant cystic fibrosis transmembrane conductance regulator from Chinese hamster ovary and insect cells.
O'Riordan CR; Erickson A; Bear C; Li C; Manavalan P; Wang KX; Marshall J; Scheule RK; McPherson JM; Cheng SH
J Biol Chem; 1995 Jul; 270(28):17033-43. PubMed ID: 7542655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
